Clover Health Investments (NAS:CLOV) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Clover Health Investments Forward PE Ratio Related Terms
Clover Health Investments Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments Forward PE Ratio Chart
Clover Health Investments Annual Data
Trend
Forward PE Ratio
Clover Health Investments Quarterly Data
Forward PE Ratio
CLOV vs PGNY, ALHC, PFHO: Forward PE Ratio Comparison
For the Healthcare Plans subindustry, Clover Health Investments's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Health Investments Forward PE Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's Forward PE Ratio falls into.
Clover Health Investments Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Clover Health Investments (CLOV) has a Forward PE Ratio of 341.54 as of Jul. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #15 out of 15 companies in the Healthcare Plans industry.
Is Clover Health Investments' Forward PE Ratio too high?
Clover Health Investments' current Forward PE Ratio is 341.54. The Healthcare Plans industry median Forward PE Ratio is 23.97. Clover Health Investments' value of 341.54 is 1324.9% above this industry median. Based on the distribution chart, Clover Health Investments ranks #15 out of 15 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Clover Health Investments has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Forward PE Ratio compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #15 out of 15 companies for Forward PE Ratio. This places Clover Health Investments in the lower half of its industry. The industry median Forward PE Ratio is 23.97. Clover Health Investments' value of 341.54 is 1324.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Plans company?
The median Forward PE Ratio among Healthcare Plans companies is 23.97, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clover Health Investments's current Forward PE Ratio of 341.54 is 1324.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median Forward PE Ratio is 23.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current Forward PE Ratio is 341.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.01, compared to a current price of $4.44 — trading 10.7% above its estimated fair value. The current Forward PE Ratio is 341.54 and 1324.9% above the Healthcare Plans industry median of 23.97. Clover Health Investments' overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Forward PE Ratio is 341.54 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clover Health Investments (CLOV) Overvalued in 2026?
Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued.
The current stock price of $4.44 is trading 10.7% above its estimated GF Value™ of $4.01.
GuruFocus considers Clover Health Investments to be Modestly Overvalued.
Key valuation signals for CLOV:
Forward PE Ratio: 341.54
GF Value™: $4.01 vs. price of $4.44 (10.7% above fair value)
Industry Position: 1324.9% above the Healthcare Plans median (#15 of 15)
No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
83GF Score
Get the complete analysis for CLOV
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLOV has been successfully added to your 